her Search Results


95
Miltenyi Biotec erbb2
Erbb2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/erbb2/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
erbb2 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

95
Carna Inc 05cbs
05cbs, supplied by Carna Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/05cbs/product/Carna Inc
Average 95 stars, based on 1 article reviews
05cbs - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

95
Proteintech erbb2
Erbb2, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/erbb2/product/Proteintech
Average 95 stars, based on 1 article reviews
erbb2 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

93
OriGene pcmv6 vector
Pcmv6 Vector, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcmv6 vector/product/OriGene
Average 93 stars, based on 1 article reviews
pcmv6 vector - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Addgene inc pmrx ib mruby3 ftl
Pmrx Ib Mruby3 Ftl, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pmrx ib mruby3 ftl/product/Addgene inc
Average 93 stars, based on 1 article reviews
pmrx ib mruby3 ftl - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Boster Bio c erbb 2
C Erbb 2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c erbb 2/product/Boster Bio
Average 93 stars, based on 1 article reviews
c erbb 2 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc her erbb family antibody sample kit
Her Erbb Family Antibody Sample Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/her erbb family antibody sample kit/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
her erbb family antibody sample kit - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
OriGene type myc ddk
Type Myc Ddk, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/type myc ddk/product/OriGene
Average 90 stars, based on 1 article reviews
type myc ddk - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

95
Carna Inc her2 kinase
Her2 Kinase, supplied by Carna Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/her2 kinase/product/Carna Inc
Average 95 stars, based on 1 article reviews
her2 kinase - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

90
OriGene her2 gfp
Her2 Gfp, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/her2 gfp/product/OriGene
Average 90 stars, based on 1 article reviews
her2 gfp - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

91
Miltenyi Biotec erbb3 apc
Erbb3 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/erbb3 apc/product/Miltenyi Biotec
Average 91 stars, based on 1 article reviews
erbb3 apc - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

95
Miltenyi Biotec apc anti human cd340 ab
The percentages of live and apoptotic cells were determined by FACS analysis (see Materials and Methods section). ( A ) Representative dot plot of FACS analysis of treated PC14 cells stained with annexin-V FITS and PI. PC14 singlet-cell events are distinguished from target cells by the <t>CD340</t> specific marker. Numbers in the quadrants are the percentages of PC14 cells within each quadrant. ( B , C ) Quantitative results of FACS analysis. B. Percentage of live (low PI, low annexin V) PC14 cells cultured alone, with astrocytes, alone plus Taxol, with astrocytes in a contact-dependent manner (mixed co-culture) plus Taxol, and with astrocytes in a contact-independent manner (separated by a transwell membrane (TW)) plus Taxol. Results are expressed as percentages of untreated PC14 cells. C. Apoptotic (high annexin V, low PI) PC14 cells cultured alone, with astrocytes, alone plus Taxol, with astrocytes in a contact-dependent manner plus Taxol, and with astrocytes in a transwell (TW) plus Taxol. The results are expressed as percentage of total cells and are presented as means ± SEM. Analysis (One-way ANOVA) revealed significant differences in live cell percentages and apoptotic cells between annexin V-stained and PI-stained cells, P < 0.05. Post-hoc analysis was performed by Fisher's LSD: * P < 0.05, ** P = 0.01, **** P < 0.0001; n = 4.
Apc Anti Human Cd340 Ab, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apc anti human cd340 ab/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
apc anti human cd340 ab - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

Image Search Results


The percentages of live and apoptotic cells were determined by FACS analysis (see Materials and Methods section). ( A ) Representative dot plot of FACS analysis of treated PC14 cells stained with annexin-V FITS and PI. PC14 singlet-cell events are distinguished from target cells by the CD340 specific marker. Numbers in the quadrants are the percentages of PC14 cells within each quadrant. ( B , C ) Quantitative results of FACS analysis. B. Percentage of live (low PI, low annexin V) PC14 cells cultured alone, with astrocytes, alone plus Taxol, with astrocytes in a contact-dependent manner (mixed co-culture) plus Taxol, and with astrocytes in a contact-independent manner (separated by a transwell membrane (TW)) plus Taxol. Results are expressed as percentages of untreated PC14 cells. C. Apoptotic (high annexin V, low PI) PC14 cells cultured alone, with astrocytes, alone plus Taxol, with astrocytes in a contact-dependent manner plus Taxol, and with astrocytes in a transwell (TW) plus Taxol. The results are expressed as percentage of total cells and are presented as means ± SEM. Analysis (One-way ANOVA) revealed significant differences in live cell percentages and apoptotic cells between annexin V-stained and PI-stained cells, P < 0.05. Post-hoc analysis was performed by Fisher's LSD: * P < 0.05, ** P = 0.01, **** P < 0.0001; n = 4.

Journal: Oncotarget

Article Title: Intercellular transfer of small RNAs from astrocytes to lung tumor cells induces resistance to chemotherapy

doi: 10.18632/oncotarget.7273

Figure Lengend Snippet: The percentages of live and apoptotic cells were determined by FACS analysis (see Materials and Methods section). ( A ) Representative dot plot of FACS analysis of treated PC14 cells stained with annexin-V FITS and PI. PC14 singlet-cell events are distinguished from target cells by the CD340 specific marker. Numbers in the quadrants are the percentages of PC14 cells within each quadrant. ( B , C ) Quantitative results of FACS analysis. B. Percentage of live (low PI, low annexin V) PC14 cells cultured alone, with astrocytes, alone plus Taxol, with astrocytes in a contact-dependent manner (mixed co-culture) plus Taxol, and with astrocytes in a contact-independent manner (separated by a transwell membrane (TW)) plus Taxol. Results are expressed as percentages of untreated PC14 cells. C. Apoptotic (high annexin V, low PI) PC14 cells cultured alone, with astrocytes, alone plus Taxol, with astrocytes in a contact-dependent manner plus Taxol, and with astrocytes in a transwell (TW) plus Taxol. The results are expressed as percentage of total cells and are presented as means ± SEM. Analysis (One-way ANOVA) revealed significant differences in live cell percentages and apoptotic cells between annexin V-stained and PI-stained cells, P < 0.05. Post-hoc analysis was performed by Fisher's LSD: * P < 0.05, ** P = 0.01, **** P < 0.0001; n = 4.

Article Snippet: The cells were incubated at 37°C in a humidified 5% CO 2 incubator for 6 h, harvested, and stained for 15 min at RT with APC anti-human CD340 Ab to label PC14 cells and with anti-mouse GLAST-PE conjugated antibody (Miltenyi Biotec) to label astrocytes.

Techniques: Staining, Marker, Cell Culture, Co-Culture Assay, Membrane

PC14 cells (CD340 positive) containing 22bpCy3 were assayed by FACS analysis (see Materials and Methods section). ( A ) Time course of 22bpCy3 transfer from astrocytes to PC14 cells. B−G. Representative dot plots of the results of FACS analysis after the different treatments, depicting total live-cell gate records. ( B ) PC14 cells (CD340 positive) alone. ( C ) 22bpCy3-transfected astrocytes (Cy3 positive) alone; positive for Cy3. D, E. PC14 cells co-cultured with astrocytes-22bpCy3 in a contact-dependent ( D ) or contact-independent (transwell, TW) manner ( E ) F, G. Astrocytes-22bpCy3 were co-cultured with PC14 cells that were untreated (control) ( F ) or treated with RNase A/T ( G ) ( H ) Quantitative results of FACS analysis, expressed as mean fluorescence intensity (MFI) of 22bpCy3 recorded in the PC14 cells and presented as means ± SEM. Analysis (One-way ANOVA) revealed significant differences in MFI of 22bpCy3 between the groups: P < 0.05. Post-hoc analysis by Fisher's LSD yielded * P < 0.05, ** P < 0.01, **** P < 0.0001; n = 5.

Journal: Oncotarget

Article Title: Intercellular transfer of small RNAs from astrocytes to lung tumor cells induces resistance to chemotherapy

doi: 10.18632/oncotarget.7273

Figure Lengend Snippet: PC14 cells (CD340 positive) containing 22bpCy3 were assayed by FACS analysis (see Materials and Methods section). ( A ) Time course of 22bpCy3 transfer from astrocytes to PC14 cells. B−G. Representative dot plots of the results of FACS analysis after the different treatments, depicting total live-cell gate records. ( B ) PC14 cells (CD340 positive) alone. ( C ) 22bpCy3-transfected astrocytes (Cy3 positive) alone; positive for Cy3. D, E. PC14 cells co-cultured with astrocytes-22bpCy3 in a contact-dependent ( D ) or contact-independent (transwell, TW) manner ( E ) F, G. Astrocytes-22bpCy3 were co-cultured with PC14 cells that were untreated (control) ( F ) or treated with RNase A/T ( G ) ( H ) Quantitative results of FACS analysis, expressed as mean fluorescence intensity (MFI) of 22bpCy3 recorded in the PC14 cells and presented as means ± SEM. Analysis (One-way ANOVA) revealed significant differences in MFI of 22bpCy3 between the groups: P < 0.05. Post-hoc analysis by Fisher's LSD yielded * P < 0.05, ** P < 0.01, **** P < 0.0001; n = 5.

Article Snippet: The cells were incubated at 37°C in a humidified 5% CO 2 incubator for 6 h, harvested, and stained for 15 min at RT with APC anti-human CD340 Ab to label PC14 cells and with anti-mouse GLAST-PE conjugated antibody (Miltenyi Biotec) to label astrocytes.

Techniques: Transfection, Cell Culture, Control, Fluorescence

Astrocytes-22bpCy3 were co-cultured with MDA-MB-231 cells for 6 h. MDA-MB-231 cells (CD340 positive) containing 22bpCy3 were assayed by FACS analysis (see Materials and Methods section). ( A − E ) Representative dot plots of the results of FACS analysis after the different treatments, depicting total live-cell gate records A. MDA-MB-231 cells (positive for CD340) alone. B. 22bpCy3-transfected astrocytes (Cy3-positive) alone. C, D. MDA-MB-231 cells co-cultured with astrocytes-22bpCy3 in a contact-dependent (C) or contact-independent (transwell, TW) manner (D). E. MDA-MB-231 cells co-cultured with astrocytes-22bpCy3 treated with RNase A/T. ( F ) Quantitative results of the FACS analysis, expressed as MFI of 22bpCy3 recorded in the MDA-MB-231 cells and presented as means ± SEM. Analysis (One-way ANOVA) revealed significant differences in MFI of 22bpCy3 between the groups: P < 0.01. Post-hoc analysis by Fisher's LSD yielded ** P < 0.01; n = 5.

Journal: Oncotarget

Article Title: Intercellular transfer of small RNAs from astrocytes to lung tumor cells induces resistance to chemotherapy

doi: 10.18632/oncotarget.7273

Figure Lengend Snippet: Astrocytes-22bpCy3 were co-cultured with MDA-MB-231 cells for 6 h. MDA-MB-231 cells (CD340 positive) containing 22bpCy3 were assayed by FACS analysis (see Materials and Methods section). ( A − E ) Representative dot plots of the results of FACS analysis after the different treatments, depicting total live-cell gate records A. MDA-MB-231 cells (positive for CD340) alone. B. 22bpCy3-transfected astrocytes (Cy3-positive) alone. C, D. MDA-MB-231 cells co-cultured with astrocytes-22bpCy3 in a contact-dependent (C) or contact-independent (transwell, TW) manner (D). E. MDA-MB-231 cells co-cultured with astrocytes-22bpCy3 treated with RNase A/T. ( F ) Quantitative results of the FACS analysis, expressed as MFI of 22bpCy3 recorded in the MDA-MB-231 cells and presented as means ± SEM. Analysis (One-way ANOVA) revealed significant differences in MFI of 22bpCy3 between the groups: P < 0.01. Post-hoc analysis by Fisher's LSD yielded ** P < 0.01; n = 5.

Article Snippet: The cells were incubated at 37°C in a humidified 5% CO 2 incubator for 6 h, harvested, and stained for 15 min at RT with APC anti-human CD340 Ab to label PC14 cells and with anti-mouse GLAST-PE conjugated antibody (Miltenyi Biotec) to label astrocytes.

Techniques: Cell Culture, Transfection

( A , B ) The gap-junction inhibitor CBX inhibits transfer of 22bpCy3 from astrocytes to PC14 cells. PC14 cells (CD340 positive) containing 22bpCy3 were assayed by FACS analysis (see Materials and Methods section). A. Representative dot plots of the results of FACS analysis after the different treatments, depicting total live-cell gate records. B. Quantitative results of FACS analysis expressed as MFI of 22bpCy3 recorded in PC14 cells cultured with astrocytes-22bpCy3 that were treated with CBX (50 μM/150 μM) or untreated (control). CBX inhibited the transfer of endogenous sRNA from the astrocytes to the PC14 cells. C−F. Levels of mmu-miR-16* ( C ), mmu-miR-709 ( D ), mmu-miR-1195 ( E ) and endo-siRNA-1196 ( F ) were measured in PC14-GFP cells by qPCR (see Materials and Methods section). Results are presented as means ± SEM. Analysis (One-way ANOVA revealed significant differences in MFI of 22bpCy3 between the groups: P < 0.05. Post-hoc analysis by Fisher's LSD yielded * P < 0.05, **** P < 0.0001; n = 4.

Journal: Oncotarget

Article Title: Intercellular transfer of small RNAs from astrocytes to lung tumor cells induces resistance to chemotherapy

doi: 10.18632/oncotarget.7273

Figure Lengend Snippet: ( A , B ) The gap-junction inhibitor CBX inhibits transfer of 22bpCy3 from astrocytes to PC14 cells. PC14 cells (CD340 positive) containing 22bpCy3 were assayed by FACS analysis (see Materials and Methods section). A. Representative dot plots of the results of FACS analysis after the different treatments, depicting total live-cell gate records. B. Quantitative results of FACS analysis expressed as MFI of 22bpCy3 recorded in PC14 cells cultured with astrocytes-22bpCy3 that were treated with CBX (50 μM/150 μM) or untreated (control). CBX inhibited the transfer of endogenous sRNA from the astrocytes to the PC14 cells. C−F. Levels of mmu-miR-16* ( C ), mmu-miR-709 ( D ), mmu-miR-1195 ( E ) and endo-siRNA-1196 ( F ) were measured in PC14-GFP cells by qPCR (see Materials and Methods section). Results are presented as means ± SEM. Analysis (One-way ANOVA revealed significant differences in MFI of 22bpCy3 between the groups: P < 0.05. Post-hoc analysis by Fisher's LSD yielded * P < 0.05, **** P < 0.0001; n = 4.

Article Snippet: The cells were incubated at 37°C in a humidified 5% CO 2 incubator for 6 h, harvested, and stained for 15 min at RT with APC anti-human CD340 Ab to label PC14 cells and with anti-mouse GLAST-PE conjugated antibody (Miltenyi Biotec) to label astrocytes.

Techniques: Cell Culture, Control